Jeang KT, Widen SG, Semmes OJ , Wilson SH .HTLV-I trans-acting
protein tax is a trans-repressor of the human Beta-polymerase
gene. Science 1990; 247:1082-1084.
2. Manns A, Cleghorn FR, Falk RT, Hanchard B, Jaffe ES, Bartholomew
C,
et al.
Role of HTLV-I in development of non-Hodgkin lymphoma
in Jamaica and Trinidad and Tobago. Lancet 1993; 342:1447-
1450.
3. Chindamo MC, Spector N, Segadas JA, Pimenta G, Vanderborght
B, Morais JC,
et al.
Prevalence of hepatitis C infection in patients
with non-Hodgkin lymphomas. Oncol Rep 2002; 9:657-659.
4. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F,
Bidkhori HR, Shamsian SK, Ahmadi S,
et al
. High prevalence of
HTLV-I infection in Mashhad, Northeast Iran: a population-based
seroepidemiology survey. J Clin Virol 2011; 52:172-176.
5. Uchiyama T .Human T cell leukemia Virus type 1 (HTLV-I) and human
diseases. Annu Rev Immunol 1997; 15:15-37.
6. Jeang KT, Giam CZ, Majone M .Life,death and tax: role of HTLV-I
oncoprotein in genetic instability and cellular transformation. J
Biol Chem 2004; 27:31991-31994.
7. Yenice N, Gulluk F, Arican N, Turlman S .HCV prevalence in Hodgkin
and non-Hodgkin lymphoma cases. Turk J Gasteroenterol
2003; 14:173-176.
Table 1.
Histological characteristics of NHL lymphoma samples in this study
Place of resentment
Histological forms of NHL Number GI Tract Cervical lymphatic
nodes
Inguinal lymphatic
nodes
Other sites HTLV-I positive
cases
HCV positive
cases
Disseminated 32 9 10 3 10 8 3
Nodular 6 unidentified unidentified unidentified unidentified - -
Great cell lymphomas 5 - 4 - 1 - -
Low grade lymphomas 2 - - 1 1 - 1
Burkitt’s like lymphoma 1 - 1 - - 1 -
Atypical NHL 2 - - - 2 - -
NHL with mixed cellularity 5 - 3 - 2 1 -
Total 54 9 18 4 16 10 4
246
Rastin M et al HTLV-I and HCV Prevalence in NHL
Iran J Basic Med Sci; Vol. 16, No. 3, Mar 2013
8. El-Seraq HB, Hampel H, Yeh C, Rabeneck L .Extrahepatic manifestation
of hepatitis C amoung United states male veterans. Hepathol
2002; 36:1439-1445.
9. Flint M, Quinn ER, Levy S .In search of hepatitis C virus receptor(s).
Clin Liver Dis 2001; 5: 873-893.
10. Delaporte E, Klotz F, Peeters M, Martin-Prevel Y, Bedjabaga L,
Larouze B
, et al
. Non-Hodgkin lymphoma in Gabon and its relation
to HTLV-I. Int J Cancer 1993; 53:48-50.
11. Adedayo OA, Shehu SM .Human T-cell lymphotropic virus type 1
(HTLV-I) and lymphoid malignancies in Dominica: a seroprevalence
study. Am J Hematol 2004; 77:336- 339.
12. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J .Search for
hepatitis C virus extrahepatic replication sites in patients with
acquired immunodeficiency syndrome: specific detection of
negative-strand viral RNA in various tissues. Hepatology 1998;
28:1398-1401.
13. Gisbert JP, Garcia-Buey L, Arranz R, Blas C, Pinilla I, Khorrami S,
et
al.
The prevalence of hepatitis C virus infection in patients with
non-Hodgkin’s lymphoma. Eur J Gastroenterol Hepatol 2004;
16:135-138.
14. Rabkin CS, Tess BH, Christianson RE, Wright WE, Waters DJ, Alter
HJ,
et al.
Prospective study of hepatitis C viral infection as a risk
factor for subsequent B-cell neoplasia. Blood 2002; 99:4240-
4242.
)